The European Association of Urology COVID Intermediate-priority Group is Poorly Predictive of Pathological High Risk Among Patients with Renal Tumours

[1]  Hiren V. Patel,et al.  Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond , 2020, Urologic Oncology: Seminars and Original Investigations.

[2]  Nari Shin,et al.  Postoperative Biochemical Failure in Patients With PI-RADS Category 4 or 5 Prostate Cancers: Risk Stratification According to Zonal Location of an Index Lesion. , 2020, AJR. American journal of roentgenology.

[3]  M. Babjuk,et al.  European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era☆ , 2020, European Urology.

[4]  Yu Xuan Kitzing,et al.  An update of pitfalls in prostate mpMRI: a practical approach through the lens of PI-RADS v. 2 guidelines , 2017, Insights into Imaging.

[5]  Yipeng Hu,et al.  The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy , 2017, British Journal of Cancer.

[6]  M. Parmar,et al.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confi rmatory study , 2018 .

[7]  H. Ahmed,et al.  Transperineal template prostate‐mapping biopsies: an evaluation of different protocols in the detection of clinically significant prostate cancer , 2016, BJU international.

[8]  J. Brooks,et al.  Biologic differences between peripheral and transition zone prostate cancer , 2015, The Prostate.

[9]  M. Roethke,et al.  Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: a standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics , 2013, BJU international.

[10]  Lars Egevad,et al.  International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume , 2011, Modern Pathology.

[11]  John T. Wei.  Limitations of a contemporary prostate biopsy: the blind march forward. , 2010, Urologic oncology.

[12]  Xavier Leroy,et al.  Peripheral zone prostate cancers: Location and intraprostatic patterns of spread at histopathology , 2009, The Prostate.

[13]  M. Melamed,et al.  Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate--a 4-year experience. , 2007, Urology.

[14]  J. Cheville,et al.  Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma , 2003, Cancer.

[15]  T. Stamey,et al.  The role of perineural space invasion in the local spread of prostatic adenocarcinoma. , 1989, The Journal of urology.

[16]  T. Klatte,et al.  European Association of Urology COVID intermediate prioritisation group is poorly predictive of pathological high- risk among patients with renal tumours , 2021, VIRTUAL ACADEMIC SURGERY CONFERENCE 2021 CONFERENCE PROCEEDINGS.

[17]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[18]  J. McNeal,et al.  The zonal anatomy of the prostate , 1981, The Prostate.